
Denmark
Danish Centre for Strategic Research in Type 2 Diabetes
The Danish Center for Strategic Research in Type II Diabetes (DD2) aims to improve treatment and long-term outcomes of patients with newly diagnosed type 2 diabetes (T2D). The overall goal is to near-normalize metabolic control in patients, using an individualized treatment approach. The biobank includes samples from 50,000 patients with newly diagnosed T2D.